GlassScriptPhysician profile
Byron Haitas
NPI 1275646119
$2,081.88
in general payments reported to CMS, 2019-2025
23 companies · $360 in 2025
The $360 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $15.13 · 2021: $220 · 2022: $395 · 2023: $631 · 2024: $354 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $568.30 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Novartis Pharmaceuticals Corporation | $152.44 | 2019-2025 | |
| Abbott Laboratories | $138.86 | 2023-2025 | Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $135.90 | 2019-2025 | Farapulse, Watchman Flx |
| Pfizer INC. | $123.29 | 2023-2025 | |
| United Therapeutics Corporation | $122.84 | 2024-2025 | Tyvaso, Tyvaso |
| Novo Nordisk INC | $112.73 | 2023 | Rybelsus, Ozempic, Wegovy |
| Shockwave Medical, INC | $111.19 | 2023-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $100.17 | 2022-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.81 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.64 | 2021 | |
| Inari Medical, INC. | $47.73 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $47.14 | 2025 | Ecc Solutions |
| Merck Sharp & Dohme LLC | $47.08 | 2022 | |
| Abiomed | $44.10 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $40.83 | 2022-2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $38.65 | 2024 | |
| Spectrawave, INC | $33.08 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Astrazeneca Pharmaceuticals LP | $26.33 | 2023 | Brilinta, Wainua |
| Inspire Medical Systems, INC. | $22.77 | 2023 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $18.04 | 2024 | Arcalyst |
| Ekos Corporation | $14.96 | 2019 | |
| Organogenesis INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Haitas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.